In research that could impact how to treat osteoporsis in the future, a new bone–forming growth factor, osteolectin, has been discovered to reverse the disease in mice and promote the formation of new bone from skeletal stem cells in the bone marrow. More on this exciting research can be found here: https://www.mdlinx.com/orthopedics/top-medical-news/article/2016/12/22/1